Navigation Links
Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
Date:9/18/2008

he same site as Inner Mongolia's 2,000 TPA production facility. The new facility is now scheduled to be completed by the middle of October 2008 and to be fully operational in the first quarter of 2009, which will increase our potential production capacity a total of 400%.

Rich Pipeline of New Products

We are developing a number of new nutrient products that target specific plants and animals. We currently produce a universal plant nutrient product. The Company is developing specialized products that will target corn, la jiao peppers, wheat, rice, cucumbers, tomatoes, cotton, potatoes, sunflowers, grapes, tropical fruits and flowers. Our animal nutrient product is for dairy cows. Specialized nutrient products are being developed that will focus on hogs, poultry and sheep. We expect to increase our sales revenue by targeting specific plant needs and providing nutrients to more types of livestock and will roll these out according to our market strategy.

Outstanding Financial Results

Our strong product portfolio and growing distribution footprint resulted in outstanding financial performance in the first half of 2008. Net revenue grew by 232.0% to $27.0 million in the six months ended June 30, 2008, up from $8.1 million in the six months ended June 30, 2007. Gross profit was $14.6 million in the same period, representing a gross margin of 54.0%, as compared to gross profit of $3.8 million, or a gross margin of 46.5%, in the six months ended June 30, 2007. Net income was $7.7 million, or $0.54 per diluted share, compared to $3.4 million, or $0.29 per diluted share, in the six months ended June 30, 2007. As in the first six months of 2008, we expect the remaining two quarters to conform to plan for 2008 and lead towards our net income "make good" target of $10.3 million which we provided to investors as part of both of our private placement transactions.

Upcoming Visit to the United States

In the second half of September, Yongye s
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... pacemakers may inadequately stimulate a patient,s heart while ... to the magnetic pulses mixing with the electronic ... is potentially dangerous for the patient undergoing the ... Central,s open access journal BioMedical Engineering Online ... uses a magnetic field instead of ionizing radiation ...
(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) ... and fiscal year ended October 31, 2009. Revenues for ... $90.4 million in the fourth quarter of fiscal 2008. ... share, for the fourth quarter of fiscal 2009, a ... diluted share, in last year,s fourth quarter. The ...
(Date:12/16/2009)... , ... Argonne, Ill. (Vocus) ... Energy’s (DOE) Argonne National Laboratory and Northwestern University, Evanston, ... in a solution, providing insights for design of bio-inspired dynamically ... million times more massive than the bacteria,” said physicist and ...
(Date:12/16/2009)... Decision Resources, one of the world,s leading research ... finds that, according to responses from surveyed dermatologists, ... interleukin inhibitors) will capture 22 percent of the ... for moderate to severe psoriasis. Among these two ... three times as much patient share as briakinumab. ...
Breaking Biology Technology:FDA researchers identify new MRI safety risk for patients with pacemakers 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
... 20 Percent of Patients Diagnosed with the Disease Receive,Pharmacotherapy Within a ... ... Decision Resources, WALTHAM, Mass., April 7, 2008 Decision Resources, ... issues, finds that Boehringer Ingelheim,s Flomax, also marketed,as Astellas,s Harnal in ...
... 2008 Light Sciences Oncology,Inc. (LSO) today announced the ... The appointment increases Board membership to eight., Holveck, ... Director,of Endo Pharmaceuticals. He is the former President of ... Corporate Development with,Johnson & Johnson (NYSE: JNJ ). ...
... MENLO PARK, Calif., April 7, 2008 ... internationally renowned,scientists to the venture capital firm,s ... pioneer Dr. Leroy Hood, and,former FDA commissioner ... InterWest,s,roster of experienced professional advisors, providing strategic ...
Other Biology Technology:More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy 2More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy 3Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors 2Prestigious Scientific Leaders Join InterWest Advisory Committee 2Prestigious Scientific Leaders Join InterWest Advisory Committee 3Prestigious Scientific Leaders Join InterWest Advisory Committee 4
(Date:12/16/2009)... Calif. and PALM HARBOR, Fla., Dec. 2 ... Bulletin Board: CICI), a leading supplier of ... in the financial industry* and the recognized ... Systems Inc. ("Docubase"), a leading International Electronic ... that they have entered an agreement to ...
(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...
(Date:12/15/2009)... soon as babies are born, they are susceptible to ... up to a month, their immune systems aren,t adequately ... minor, they can lead to serious problems if left ... Missouri researchers have pinpointed a group of depleted white ... , "We,re trying to improve the immune system of ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Researchers work on vaccine to improve immune system in newborns 2New nanocrystalline diamond probes overcome wear 14803 1New nanocrystalline diamond probes overcome wear 14803 2Speedus Corp Names Stephen X Graham to Board of Directors 61195 1Speedus Corp Names Stephen X Graham to Board of Directors 61195 2SC Johnson Makes Commitment to Clinton Global Initiative 61192 1SC Johnson Makes Commitment to Clinton Global Initiative 61192 2SC Johnson Makes Commitment to Clinton Global Initiative 61192 3
... 9, 2008 The Indonesian government and World Wildlife ... the remaining forests and critical ecosystems of Sumatra, an ... diverse and endangered forests. The historic agreement ... biodiversity. , The commitment has been endorsed by governors ...
... The National Institute of Allergy and Infectious Diseases (NIAID), ... award five-year contracts estimated to be up to $68.7 ... Disease Research at four research institutions. Scientists at each ... include severe acute respiratory syndrome (SARS), tuberculosis and influenza. ...
... researchers at North Carolina State University is leading to ... grown and harvested from freshwater ponds, instead of from ... because the pond-raised crabs look and taste just like ... population has been at historic lows since 2000. Dr. ...
Other Biology News:Saving Sumatra: Indonesia reaches historic agreement 2New Systems Biology Awards enable detailed study of microbes 2Turning freshwater farm ponds into crab farms 2
... Works fast and effectively in tubes and 96 ... simple, one tube, one and a half spin ... clean up or concentrate any type of double ... primer dimers or dNTPs (labelled or unlabelled). It ...
... 96 x 0.2 ml tubes or a ... a thumbwheel to adjust height and pressure ... cycling. Peltier heat pumps produce uniform, accurate ... of up to 1.4 degrees C per ...
... The DTX Series Multimode Detectors ... a variety of application and automation ... and absorbance measurements on the same ... as standalone instruments or can be ...
Sf21 Insect Cells (Live) in Max-XP Medium...
Biology Products: